Dianthus Therapeutics, Inc. · NASDAQ:DNTH
Veness Adam M sold 20,000 Dianthus Therapeutics, Inc. shares (Form 4)
Traded Aug 7 to Aug 10, 2026 · Filed Aug 11, 2026
From Aug 7 to Aug 10, 2026, Veness Adam M (SVP, General Counsel and Sec.) sold 20,000 Dianthus Therapeutics, Inc. shares at an average US$110.44 for US$2.21M under a trading plan, leaving 0 shares. Filed Aug 11, 2026 (Form 4).
- Sold
- 20,000 shares
- Price
- US$110.44 average (US$110.38 to US$111.18)
- Value
- US$2.21M
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- SVP, General Counsel and Sec.
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Common Stock | Option exercise | 3,833 | US$17.88 | 3,833 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 3,217 | US$110.61 | 616 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 616 | US$111.18 | 0 | Direct |
| Aug 10, 2026 | Common Stock | Option exercise | 16,167 | US$17.88 | 16,167 | Direct |
| Aug 10, 2026 | Common Stock | Sale | 16,167 | US$110.38 | 0 | Direct |
Source
Related
- Dianthus Therapeutics, Inc.
- Veness Adam M
- Dianthus Therapeutics, Inc. shareholders
- Form 4 · Veness Adam M · Aug 14, 2026
- Form 4 · Veness Adam M · Jun 18, 2026
- Form 4 · Carr Edward · Sep 18, 2026
- Form 4 · Randhawa Simrat · Sep 3, 2026
- Form 4 · Read Simon · Aug 19, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G · Wellington Management Group LLP · Aug 13, 2026